MedTrace Logo

Predictors of Subclinical Atherosclerotic Cardiovascular Diseases (ASCVD) in Patients With Inflammatory Bowel Disease

NCT03868332 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2019-03-11

No results posted yet for this study

Summary

Heart disease and failure are the major causes of mortality and morbidity worldwide, despite significant advances in medical technologies in the diagnosis and treatment of the disease. Cardiovascular disease may arise for various reasons including the steadily increasing incidence of obesity, type 2 diabetes, genetic, environmental, dietary and lifestyle factors. Besides all these, there is much evidence suggetsing that inflammation is an important player in the pathogenesis of heart disease, as well as atherogenesis and atherosclerosis.

Conditions

  • Inflammatory Bowel Diseases

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Hussien Ahmed EL-Amen, MD · Assiut University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-20
Primary Completion
2021-03-20
Completion
2021-03-20

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03868332 on ClinicalTrials.gov